0001144204-19-029895.txt : 20190605
0001144204-19-029895.hdr.sgml : 20190605
20190605163210
ACCESSION NUMBER: 0001144204-19-029895
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190603
FILED AS OF DATE: 20190605
DATE AS OF CHANGE: 20190605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dallas Matthew D
CENTRAL INDEX KEY: 0001612396
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35853
FILM NUMBER: 19880066
MAIL ADDRESS:
STREET 1: AVEO PHARMACEUTICALS, INC.
STREET 2: 650 EAST KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biostage, Inc.
CENTRAL INDEX KEY: 0001563665
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 455210462
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: (774) 233-7300
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
FORMER COMPANY:
FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc.
DATE OF NAME CHANGE: 20121204
4
1
tv523168_form4.xml
FORM 4
X0306
4
2019-06-03
0
0001563665
Biostage, Inc.
BSTG
0001612396
Dallas Matthew D
C/O BIOSTAGE, INC.
84 OCTOBER HILL ROAD, SUITE 11
HOLLISTON
MA
01746
1
0
0
0
Stock Option (right to buy)
2.90
2019-06-03
4
A
0
10364
0
A
2029-06-03
Common Stock, par value $0.01 per share
10364
10364
D
Stock Option (right to buy)
2.90
2019-06-03
4
A
0
8411
0
A
2029-06-03
Common Stock, par value $0.01 per share
8411
18775
D
This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 3, 2019, December 3, 2019, March 3, 2020, and June 3, 2020.
This Stock Option was granted in lieu of 2019 cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2019, September 30, 2019, and December 31, 2019.
This form has been signed under power of attorney.
/s/ Chad Porter, by power of attorney
2019-06-05